Biotech | March 04, 2022
Oragenics announces positive data on Covid-19 intranasal vaccine
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
12-week certificate course commences on March 10th 2022
This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine
These results are being presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Topline results from the randomized EMPATHY Part A study in acute Covid-19 ambulatory patients comparing single intravenous doses of ensovibep, a DARPin antiviral therapeutic candidate vs. placebo, met the primary endpoint of viral load reduction over eight days
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
Effectiveness of Covaxin against the Omicron variant is currently being studied
Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed
Subscribe To Our Newsletter & Stay Updated
